Table 5.
Parameter | Control subjects N=33 | Statin users N=40 | |||
---|---|---|---|---|---|
DM N=25 | CVD N=9 | HL N=6 | |||
Biseps | Amplitude (mV) | 1.85 ± 0.61 | 1.33 ± 0.36‡ | 1.4 ± 0.4‡ | 1.5 ± 0.48† |
Brachii | Duration (ms) | 13.87 ± 4.1 | 12.69 ± 5.06* | 12.69 ± 4.46 | 13.02 ± 4.11 |
Tibialis | Amplitude (mV) | 1.73 ± 1.02 | 1.64 ± 0.58 | 1.55 ± 0.58 | 1.65 ± 0.58 |
Anterior | Duration (ms) | 12.75 ± 4.39 | 14.07 ± 4.5** | 12.87 ± 4.04 | 14.15 ± 4.74 |
= P<0.05,
= P<0.01,
= P<0.0005,
= P<0.0001 (ANOVA test), (statin users vs control subjects), MUPs= Motor unit potentials, DM= diabetes mellitus, CVD= cardiovascular disease, HL= hyperlipidemia